American Society of Echocardiography recommendations for use of echocardiography in clinical trials.

By J. Gottdiener, J. Bednarz, R. Devereux, J. Gardin, A. Klein, Warren J. Manning, A. Morehead, D. Kitzman, J. Oh, M. Quiñones and 3 more. Journal of the American Society of Echocardiography, 2004

999 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/80d25e1f2e529b70a376bfe952c440e4510e0a95

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Frank Flachskampf
2. James B. Seward
3. Patricia A. Pellikka

In Radiology, Nuclear Medicine and Imaging

1. Frank Flachskampf
2. Patricia A. Pellikka

Citations in the corpus

• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio (2005, methodology): “In clinical practice, LV chamber dimensions are commonly used to derive measures of LV systolic function, whereas in epidemiologic studies and treatment trials, the single largest application of echocardiography has been the estimation of LV mass in populations and its change with antihypertensive t”
• Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. (2010, methodology): “LV mass can be calculated from M-mode or 2D linear measurements,(98-100) and this approach has been used extensively in adult clinical trials and epidemiologic studies.(1,100) It has been used in children,(101-103) though accuracy and reproducibility data, especially in infants, are scant.”
• Recommendations for chamber quantification. (2006, methodology): “In clinical practice, LV chamber dimensions are commonly used to derive measures of LV systolic function, whereas in epidemiologic studies and treatment trials, the single largest application of echocardiography has been the estimation of LV mass in populations and its change with antihypertensive t”